Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy
- 30 September 2005
- journal article
- case report
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 11 (6), 381-386
- https://doi.org/10.1016/j.parkreldis.2005.06.005
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's diseaseMovement Disorders, 2004
- Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatumJournal of Neural Transmission, 2003
- Possible Zoophilia Associated with Dopaminergic Therapy in Parkinson DiseaseAnnals of Pharmacotherapy, 2002
- Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptorsEuropean Journal of Pharmacology, 1999
- Clozapine for dopaminergic‐induced paraphilias in Parkinson's diseaseMovement Disorders, 1998
- Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain.Proceedings of the National Academy of Sciences, 1994
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Hypersexuality with Antiparkinsonian TherapyClinical Neuropharmacology, 1989